Cannell & Spears’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Sell |
39,049
-24,776
| -39% | -$1.71M | 0.05% | 176 |
|
|
2025
Q1 | $4.43M | Buy |
63,825
+27,148
| +74% | +$1.89M | 0.1% | 139 |
|
|
2024
Q4 | $3.15M | Buy |
36,677
+31,696
| +636% | +$2.73M | 0.06% | 161 |
|
|
2024
Q3 | $593K | Buy |
4,981
+90
| +2% | +$10.7K | 0.01% | 284 |
|
|
2024
Q2 | $698K | Buy |
4,891
+651
| +15% | +$92.9K | 0.01% | 245 |
|
|
2024
Q1 | $544K | Buy |
4,240
+20
| +0.5% | +$2.57K | 0.01% | 274 |
|
|
2023
Q4 | $437K | Buy |
4,220
+2,000
| +90% | +$207K | 0.03% | 144 |
|
|
2023
Q3 | $202K | Buy |
+2,220
| New | +$202K | 0.02% | 200 |
|
|
2021
Q4 | – | Sell |
-11,300
| Closed | -$542K | – | 243 |
|
|
2021
Q3 | $542K | Buy |
+11,300
| New | +$542K | 0.04% | 139 |
|